Sutro Biopharma Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Sutro Biopharma Inc
TickerSTRO
CIK #0001382101
CUSIP869367102
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
Address310 Utah Ave, Suite 150, South San Francisco, CA 94080
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Sutro Biopharma Inc 2018-06-06 85.4 M Exemption: 506(b) · Remaining: $2 · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001382101] 10-K
[0001382101] 10-Q
[0001382101] 3
[0001382101] 4
[0001382101] 8-K
[0001382101] D
[0001382101] SC 13D
[0001382101] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Samsara Biocapital LP Sutro Biopharma Inc [2026-05-15] 0.0
Point72 Asset Management LP Sutro Biopharma Inc [2026-05-01] 0.0
Perceptive Advisors LLC Sutro Biopharma Inc [2026-04-21] 0.0
Biotechnology Value Fund L P Sutro Biopharma Inc [2026-02-18] 0.0
Affinity Asset Advisors LLC Sutro Biopharma Inc [2025-10-23] 0.0
Millennium Management LLC Sutro Biopharma Inc [2025-06-30] 0.0
Kynam Capital Management LP Sutro Biopharma Inc [2025-05-15] 0.0
RA Capital Management LP Sutro Biopharma Inc [2025-04-04] 0.0
Point72 Asset Management LP Sutro Biopharma Inc [2024-04-05] 7.7
Integrated Core Strategies US LLC Sutro Biopharma Inc [2024-01-17] 5.1
Adage Capital Partners GP LLC Sutro Biopharma Inc [2023-10-10] 5.86
Rubric Capital Management LP Sutro Biopharma Inc [2023-02-10] 5.59
Millennium Management LLC Sutro Biopharma Inc [2022-07-08] 5.2
Franklin Resources Inc Sutro Biopharma Inc [2022-02-04] 7.1
Biotechnology Value Fund L P Sutro Biopharma Inc [2022-01-18] 3.7
Suvretta Capital Management LLC Sutro Biopharma Inc [2021-12-10] 5.2
BlackRock Inc Sutro Biopharma Inc [2021-02-02] 6.2
EcoR1 Capital LLC Sutro Biopharma Inc [2020-08-28] 6.5
Ridgeback Capital Investments LP Sutro Biopharma Inc [2020-08-25] 5.3
Biotechnology Value Fund L P Sutro Biopharma Inc [2020-05-22] 3.5
Skyline Venture Partners V LP Sutro Biopharma Inc [2020-02-12] 8.5
Celgene Corp /DE/ Sutro Biopharma Inc [2020-02-10] 7.5
Lilly Ventures Fund I LLC Sutro Biopharma Inc [2019-02-14] 6.7
Eventide Asset Management LLC Sutro Biopharma Inc [2019-02-13] 5.4
Alta Partners VIII LP Sutro Biopharma Inc [2019-02-12] 8.5
SVLSF V LLC Sutro Biopharma Inc [2018-10-09] 3.9
Merck & Co Inc Sutro Biopharma Inc [2018-10-04] 11.9
Citadel Advisors LLC Sutro Biopharma Inc [2018-10-04] 7.7
Form 3/4/5 Filer 2011 - 2026
Hunter Heidi
Sutro Biopharma Inc
Matsui Connie
Lobacki Joseph M
Dybbs Michael
Petree Daniel H
Wigginton Jon Marc
Panek James P
Jagpal Sukhi
Chow Gregory K
Chung Jane
Pauling David
Gerber Hans-Peter
Albini Edward C
Fitzpatrick Linda A
Borgman Anne Elizabeth
Srinivasan Venkatesh
Leyman Barbara
Newell William J
Freund John Gordon
Vasquez Nicki
Shtylla Brunilda
Hallam Trevor
Shabbir Anik
Sharp Shalini
Molina Arturo MD
Janney Daniel
Worsley Stephen
Kaneko Yasunori
Skyline Venture Management V LLC
Skyline Venture Partners V LP
Merck & Co Inc
Merck Sharp & Dohme Corp
Celgene Corp /DE/
Ross Michael Jay
International Life Sciences Fund III Strategic Partners LP
International Life Sciences Fund III GP LP
SV Life Sciences Fund V GP LP
International Life Sciences Fund III Co-Investment LP
SV Life Sciences Fund V Strategic Partners LP
SV Life Sciences Fund V LP
SVLSF V LLC
ILSF III LLC
International Life Sciences Fund III LP1 LP
Alta Partners Management VIII LLC
Nohra Guy P
Champsi Farah
Alta Partners VIII LP
Lawlis V Bryan
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Chung Jane
Common Stock
2026-03-04 Tax withheld 282 $21.31 6,009
Pauling David
Common Stock
2026-03-04 Tax withheld 277 $21.31 5,903
Pauling David
Common Stock
2026-03-04 Option exercise 675 $0.00
Chung Jane
Restricted Stock Units (RSUs) · derivative
2026-03-04 Option exercise 788 $0.00
Pauling David
Restricted Stock Units (RSUs) · derivative
2026-03-04 Option exercise 675 $0.00
Chung Jane
Common Stock
2026-03-04 Option exercise 788 $0.00
Pauling David
Restricted Stock Units (RSUs) · derivative
2026-03-02 Grant 4,200 $0.00
Gerber Hans-Peter
Stock Option (right to buy) · derivative
2026-03-02 Grant 40,000 $0.00
Gerber Hans-Peter
Restricted Stock Units (RSUs) · derivative
2026-03-02 Option exercise 2,843 $0.00
Chow Gregory K
Stock Option (right to buy) · derivative
2026-03-02 Grant 40,000 $0.00
Chung Jane
Restricted Stock Units (RSUs) · derivative
2026-03-02 Grant 40,000 $0.00
Gerber Hans-Peter
Common Stock
2026-03-02 Option exercise 2,843 $0.00
Chung Jane
Common Stock
2026-03-02 Option exercise 7,750 $0.00
Pauling David
Stock Option (right to buy) · derivative
2026-03-02 Grant 33,600 $0.00
Chung Jane
Stock Option (right to buy) · derivative
2026-03-02 Grant 175,000 $0.00
Chow Gregory K
Restricted Stock Units (RSUs) · derivative
2026-03-02 Grant 5,000 $0.00
Pauling David
Common Stock
2026-03-02 Tax withheld 970 $20.55 19,934
Pauling David
Restricted Stock Units (RSUs) · derivative
2026-03-02 Option exercise 2,356 $0.00
Chung Jane
Restricted Stock Units (RSUs) · derivative
2026-03-02 Option exercise 7,750 $0.00
Gerber Hans-Peter
Common Stock
2026-03-02 Tax withheld 1,170 $20.55 24,044
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 7 290,038
2025-12-31 7 290,039
2025-09-30 88 50,079,571
2025-06-30 102 52,680,190
2025-03-31 115 58,641,561
2024-12-31 124 62,307,194
2024-09-30 131 61,066,167
2024-06-30 120 61,680,052
2024-03-31 118 53,366,950
2023-12-31 115 55,019,193
2023-09-30 110 55,225,626
2023-06-30 121 53,455,621
Form 13F Holdings
Firm Period DFND Voting Shares
Fortitude Family Office LLC [2026-06-30] SOLE 56 56
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com